标题
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
作者
关键词
-
出版物
Frontiers in Oncology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-03-07
DOI
10.3389/fonc.2018.00054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
- (2017) Darius Juskevicius et al. Journal of Hematology & Oncology
- Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease
- (2017) Thomas A. Guerrero-Garcia et al. LEUKEMIA RESEARCH
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
- (2017) Kwai Hui et al. Viruses-Basel
- The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome
- (2016) Jacob R. Bledsoe et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
- (2016) K. Georgiou et al. BLOOD
- Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
- (2016) Baoping Guo et al. BMC Medicine
- Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
- (2016) Senthamil R. Selvan et al. CURRENT CANCER DRUG TARGETS
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- HLA-G expression and role in advanced-stage classical Hodgkin lymphoma
- (2016) G. Caocci et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse
- (2016) F R Abdul Razak et al. GENES AND IMMUNITY
- Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients
- (2016) C. Laurent et al. HAEMATOLOGICA
- Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma
- (2016) H. Y. Yoo et al. HAEMATOLOGICA
- The emerging role of immune checkpoint inhibition in malignant lymphoma
- (2016) Ida Hude et al. HAEMATOLOGICA
- Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas
- (2016) Thomas Menter et al. HUMAN PATHOLOGY
- Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
- (2016) Asim Saha et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- The immune system and cancer evasion strategies: therapeutic concepts
- (2016) S. Muenst et al. JOURNAL OF INTERNAL MEDICINE
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hodgkin lymphoma: Pathology and biology
- (2016) Stephan Mathas et al. SEMINARS IN HEMATOLOGY
- PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
- (2016) Wei Xing et al. Oncotarget
- Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors
- (2016) Yang Cao et al. Oncotarget
- Addressing intra-tumoral heterogeneity and therapy resistance
- (2016) Brad Rybinski et al. Oncotarget
- Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients
- (2016) C. Laurent et al. HAEMATOLOGICA
- Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma
- (2016) H. Y. Yoo et al. HAEMATOLOGICA
- The emerging role of immune checkpoint inhibition in malignant lymphoma
- (2016) Ida Hude et al. HAEMATOLOGICA
- Classical Hodgkin Lymphoma with Reduced 2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
- (2016) M. G. M. Roemer et al. Cancer Immunology Research
- Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
- (2016) Fabio Morandi et al. Journal of Immunology Research
- PD-L1 Status in Refractory Lymphomas
- (2016) Semir Vranic et al. PLoS One
- Targetable genetic features of primary testicular and primary central nervous system lymphomas
- (2015) B. Chapuy et al. BLOOD
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Alterations of theCD58gene in classical Hodgkin lymphoma
- (2015) Markus Schneider et al. GENES CHROMOSOMES & CANCER
- Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma
- (2015) Marta Bielska et al. GENES CHROMOSOMES & CANCER
- Cancer immunotherapy: Strategies for personalization and combinatorial approaches
- (2015) Vishwanath Sathyanarayanan et al. Molecular Oncology
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein-Barr Virus– and Kaposi Sarcoma-Associated Herpesvirus–Related Malignancies in the Setting of Human Immunodeficiency Virus Infection
- (2015) Marilia Rita Pinzone et al. SEMINARS IN ONCOLOGY
- Epstein-Barr Virus–Associated Lymphomas
- (2015) Ewelina Grywalska et al. SEMINARS IN ONCOLOGY
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Antagonists of PD-1 and PD-L1 in Cancer Treatment
- (2015) Evan J. Lipson et al. SEMINARS IN ONCOLOGY
- Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
- (2015) Dachun Wang et al. Stem Cells Translational Medicine
- Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
- (2014) J. Reichel et al. BLOOD
- Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
- (2014) David D. W. Twa et al. BLOOD
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The emerging role of soluble HLA-G in the control of chemotaxis
- (2014) Fabio Morandi et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy
- (2014) Simone Muenst et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets
- (2014) M. T. M. Vossen et al. JOURNAL OF IMMUNOLOGY
- The Epstein-Barr virus and the pathogenesis of lymphoma
- (2014) Martina Vockerodt et al. JOURNAL OF PATHOLOGY
- TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin’s lymphoma
- (2014) Z-Z Yang et al. LEUKEMIA
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation
- (2014) Shuvomoy Banerjee et al. PLoS Pathogens
- Gammaherpesviruses and Lymphoproliferative Disorders
- (2013) Ethel Cesarman Annual Review of Pathology-Mechanisms of Disease
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy
- (2013) François Ghiringhelli et al. Expert Review of Clinical Immunology
- HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
- (2013) R. Rizzo et al. HAEMATOLOGICA
- The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
- (2013) D. Brusa et al. HAEMATOLOGICA
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
- (2013) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors
- (2013) Theresa Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
- (2013) Xin Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokine patterns in patients with cancer: a systematic review
- (2013) Bodo E Lippitz LANCET ONCOLOGY
- Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions
- (2013) J. Baudhuin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models
- (2012) J. H. Shin et al. BLOOD
- Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies
- (2012) L. Hoenicke et al. CARCINOGENESIS
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- More on Hemophilia A Induced by Ipilimumab
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+T cells
- (2011) Katarzyna Karwacz et al. EMBO Molecular Medicine
- PD-L2 is expressed on activated human T cells and regulates their function
- (2011) Nassima Messal et al. MOLECULAR IMMUNOLOGY
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- Hemophilia A Induced by Ipilimumab
- (2011) Julie Delyon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
- (2010) J. N. Barker et al. BLOOD
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- (2010) M. R. Green et al. BLOOD
- Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75
- (2010) M C Ryan et al. BRITISH JOURNAL OF CANCER
- Cooperative Epigenetic Modulation by Cancer Amplicon Genes
- (2010) Lixin Rui et al. CANCER CELL
- Hodgkin's cells express a novel pattern of adhesion molecules
- (2010) P. A. ELLIS et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-G expression in hematologic malignancies
- (2010) Wei-Hua Yan Expert Review of Hematology
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
- (2009) Martin J. Allday SEMINARS IN CANCER BIOLOGY
- Regulation of MHC Class I Assembly and Peptide Binding
- (2008) David R. Peaper et al. Annual Review of Cell and Developmental Biology
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- (2008) A. Bashey et al. BLOOD
- EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes
- (2008) E. Kashuba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HLA-G: from biology to clinical benefits
- (2008) Edgardo D. Carosella et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started